Jpmorgan Chase & Co »

Citius Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5k 3.0k 0.50
2024-06-30 $1.8k 3.0k 0.58
2024-03-31 $46k 51k 0.90
2023-12-31 $60k 80k 0.76
2023-09-30 $55k 80k 0.68
2023-06-30 $117k 98k 1.20
2023-03-31 $0 87 0.00
2022-12-31 $0 87 0.00
2022-06-30 $0 87 0.00
2022-03-31 $0 58k 0.00
2021-12-31 $67k 44k 1.54

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Meta Platforms Common (META)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Tesla Common (TSLA)
Vanguard S&p 500 Etf Fund (VOO)
Unitedhealth Group Common (UNH)
Eli Lilly & Co Common (LLY)
Vanguard Total Intl Bond Etf Fund (BNDX)
Ishares Core S&p 500 Etf Fund (IVV)

View all positions for Jpmorgan Chase & Co

Top funds holding Citius Pharmaceuticals

Advisor Group Holdings
IFP Advisors
TCG Advisory Services

View all funds holding Citius Pharmaceuticals